GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosenic (XBRU:BIOS) » Definitions » Issuance of Stock

Biosenic (XBRU:BIOS) Issuance of Stock : €1.55 Mil (TTM As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Biosenic Issuance of Stock?

Biosenic's Issuance of Stock for the six months ended in Jun. 2024 was €0.50 Mil.

Biosenic's Issuance of Stock for the trailing twelve months (TTM) ended in Jun. 2024 was €1.55 Mil.


Biosenic Issuance of Stock Historical Data

The historical data trend for Biosenic's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosenic Issuance of Stock Chart

Biosenic Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.52 11.78 - 0.50 1.50

Biosenic Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.45 1.05 0.50

Biosenic Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biosenic Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Biosenic's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosenic Business Description

Traded in Other Exchanges
Address
Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, BEL, 1435
Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.